163 related articles for article (PubMed ID: 23574527)
1. Accelerated tau aggregation, apoptosis and neurological dysfunction caused by chronic oral administration of aluminum in a mouse model of tauopathies.
Oshima E; Ishihara T; Yokota O; Nakashima-Yasuda H; Nagao S; Ikeda C; Naohara J; Terada S; Uchitomi Y
Brain Pathol; 2013 Nov; 23(6):633-44. PubMed ID: 23574527
[TBL] [Abstract][Full Text] [Related]
2. Effects of alpha-tocopherol on an animal model of tauopathies.
Nakashima H; Ishihara T; Yokota O; Terada S; Trojanowski JQ; Lee VM; Kuroda S
Free Radic Biol Med; 2004 Jul; 37(2):176-86. PubMed ID: 15203189
[TBL] [Abstract][Full Text] [Related]
3. A novel triple repeat mutant tau transgenic model that mimics aspects of pick's disease and fronto-temporal tauopathies.
Rockenstein E; Overk CR; Ubhi K; Mante M; Patrick C; Adame A; Bisquert A; Trejo-Morales M; Spencer B; Masliah E
PLoS One; 2015; 10(3):e0121570. PubMed ID: 25803611
[TBL] [Abstract][Full Text] [Related]
4. A novel transgenic mouse expressing double mutant tau driven by its natural promoter exhibits tauopathy characteristics.
Rosenmann H; Grigoriadis N; Eldar-Levy H; Avital A; Rozenstein L; Touloumi O; Behar L; Ben-Hur T; Avraham Y; Berry E; Segal M; Ginzburg I; Abramsky O
Exp Neurol; 2008 Jul; 212(1):71-84. PubMed ID: 18490011
[TBL] [Abstract][Full Text] [Related]
5. Accelerated human mutant tau aggregation by knocking out murine tau in a transgenic mouse model.
Ando K; Leroy K; Héraud C; Yilmaz Z; Authelet M; Suain V; De Decker R; Brion JP
Am J Pathol; 2011 Feb; 178(2):803-16. PubMed ID: 21281813
[TBL] [Abstract][Full Text] [Related]
6. Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections.
Iba M; McBride JD; Guo JL; Zhang B; Trojanowski JQ; Lee VM
Acta Neuropathol; 2015 Sep; 130(3):349-62. PubMed ID: 26150341
[TBL] [Abstract][Full Text] [Related]
7. Sex Impact on Tau-Aggregation and Postsynaptic Protein Levels in the P301L Mouse Model of Tauopathy.
Buccarello L; Grignaschi G; Castaldo AM; Di Giancamillo A; Domeneghini C; Melcangi RC; Borsello T
J Alzheimers Dis; 2017; 56(4):1279-1292. PubMed ID: 28157099
[TBL] [Abstract][Full Text] [Related]
8. Transgenic mouse models of tauopathies: prospects for animal models of Pick's disease.
Lee VM; Trojanowski JQ
Neurology; 2001 Jun; 56(11 Suppl 4):S26-30. PubMed ID: 11402147
[TBL] [Abstract][Full Text] [Related]
9. GFP-Mutant Human Tau Transgenic Mice Develop Tauopathy Following CNS Injections of Alzheimer's Brain-Derived Pathological Tau or Synthetic Mutant Human Tau Fibrils.
Gibbons GS; Banks RA; Kim B; Xu H; Changolkar L; Leight SN; Riddle DM; Li C; Gathagan RJ; Brown HJ; Zhang B; Trojanowski JQ; Lee VM
J Neurosci; 2017 Nov; 37(47):11485-11494. PubMed ID: 28986461
[TBL] [Abstract][Full Text] [Related]
10. Reducing tau aggregates with anle138b delays disease progression in a mouse model of tauopathies.
Wagner J; Krauss S; Shi S; Ryazanov S; Steffen J; Miklitz C; Leonov A; Kleinknecht A; Göricke B; Weishaupt JH; Weckbecker D; Reiner AM; Zinth W; Levin J; Ehninger D; Remy S; Kretzschmar HA; Griesinger C; Giese A; Fuhrmann M
Acta Neuropathol; 2015 Nov; 130(5):619-31. PubMed ID: 26439832
[TBL] [Abstract][Full Text] [Related]
11. Neurofibrillary tangle formation by introducing wild-type human tau into APP transgenic mice.
Umeda T; Maekawa S; Kimura T; Takashima A; Tomiyama T; Mori H
Acta Neuropathol; 2014 May; 127(5):685-98. PubMed ID: 24531886
[TBL] [Abstract][Full Text] [Related]
12. Differential induction and spread of tau pathology in young PS19 tau transgenic mice following intracerebral injections of pathological tau from Alzheimer's disease or corticobasal degeneration brains.
Boluda S; Iba M; Zhang B; Raible KM; Lee VM; Trojanowski JQ
Acta Neuropathol; 2015 Feb; 129(2):221-37. PubMed ID: 25534024
[TBL] [Abstract][Full Text] [Related]
13. GSPE interferes with tau aggregation in vivo: implication for treating tauopathy.
Santa-Maria I; Diaz-Ruiz C; Ksiezak-Reding H; Chen A; Ho L; Wang J; Pasinetti GM
Neurobiol Aging; 2012 Sep; 33(9):2072-81. PubMed ID: 22054871
[TBL] [Abstract][Full Text] [Related]
14. Inefficient induction and spread of seeded tau pathology in P301L mouse model of tauopathy suggests inherent physiological barriers to transmission.
Chakrabarty P; Hudson VJ; Sacino AN; Brooks MM; D'Alton S; Lewis J; Golde TE; Giasson BI
Acta Neuropathol; 2015 Aug; 130(2):303-5. PubMed ID: 25982997
[No Abstract] [Full Text] [Related]
15. Impaired glutamate transport in a mouse model of tau pathology in astrocytes.
Dabir DV; Robinson MB; Swanson E; Zhang B; Trojanowski JQ; Lee VM; Forman MS
J Neurosci; 2006 Jan; 26(2):644-54. PubMed ID: 16407562
[TBL] [Abstract][Full Text] [Related]
16. Lithium treatment arrests the development of neurofibrillary tangles in mutant tau transgenic mice with advanced neurofibrillary pathology.
Leroy K; Ando K; Héraud C; Yilmaz Z; Authelet M; Boeynaems JM; Buée L; De Decker R; Brion JP
J Alzheimers Dis; 2010; 19(2):705-19. PubMed ID: 20110614
[TBL] [Abstract][Full Text] [Related]
17. Pathological Tau Strains from Human Brains Recapitulate the Diversity of Tauopathies in Nontransgenic Mouse Brain.
Narasimhan S; Guo JL; Changolkar L; Stieber A; McBride JD; Silva LV; He Z; Zhang B; Gathagan RJ; Trojanowski JQ; Lee VMY
J Neurosci; 2017 Nov; 37(47):11406-11423. PubMed ID: 29054878
[TBL] [Abstract][Full Text] [Related]
18. Neuroprotective effects of Cerebrolysin in triple repeat Tau transgenic model of Pick's disease and fronto-temporal tauopathies.
Rockenstein E; Ubhi K; Mante M; Florio J; Adame A; Winter S; Brandstaetter H; Meier D; Masliah E
BMC Neurosci; 2015 Nov; 16():85. PubMed ID: 26611895
[TBL] [Abstract][Full Text] [Related]
19. Tau reduction prevents neuronal loss and reverses pathological tau deposition and seeding in mice with tauopathy.
DeVos SL; Miller RL; Schoch KM; Holmes BB; Kebodeaux CS; Wegener AJ; Chen G; Shen T; Tran H; Nichols B; Zanardi TA; Kordasiewicz HB; Swayze EE; Bennett CF; Diamond MI; Miller TM
Sci Transl Med; 2017 Jan; 9(374):. PubMed ID: 28123067
[TBL] [Abstract][Full Text] [Related]
20. Transgenic mouse model of tauopathies with glial pathology and nervous system degeneration.
Higuchi M; Ishihara T; Zhang B; Hong M; Andreadis A; Trojanowski J; Lee VM
Neuron; 2002 Aug; 35(3):433-46. PubMed ID: 12165467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
